AN AWARD-WINNING spinout company from the University of St Andrews has received a major funding boost to take on the healthcare market.

MOFgen, which is pioneering cutting-edge technology for coating medical devices, has received investment totalling £300,000 from Mercia Fund Management and the Scottish Investment Bank. The investment will allow MOFgen to develop further products that will reduce Healthcare Acquired Infections (HAIs), prevent procedural complications and improve healing rates.

“We believe our technology will make a significant difference for those who suffer from chronic wounds and secondary infections,” said Professor Russell Morris, chief scientific officer at MOFgen.